Excellent
Fully Aligned
Patient Risk:
Low
Summary
The AI claim accurately reflects the boxed warning and labeling details regarding increased risk of suicidal thoughts/behaviors in pediatric patients and the need for close monitoring, especially early in treatment and around dose changes.
Category Scores
Accurate Statements
Antidepressants (including TRINTELLIX) increase the risk of suicidal thoughts and behaviors in pediatric patients and require close monitoring, especially early in treatment and when doses are adjusted.
Boxed Warning and Warnings/Precautions (5.1) state antidepressants increase risk in pediatric patients (and young adults), and advise close monitoring especially during initial months and at times of dosage changes; Pediatric Use (8.4) reiterates pediatric risk and that safety/effectiveness are not established; Patient Counseling (17) advises watching for suicidal ideation/behavior, especially early and when dose is adjusted.
Unsupported Statements
Contradictions
Important Omissions
Safety Assessment
Potential Patient Risk:
Low
The evaluated statement is consistent with the labeled boxed warning and associated monitoring/counseling language; it does not introduce incorrect safety guidance.
Regulatory Assessment
| On Label |
Yes
| Off-label Discussion |
Yes
| Promotes Unapproved Use |
Yes
| Hallucination Risk |
Low |
Recommendation
Fully Aligned
Primary Issue
Suggested Improvement